Latest autoimmune diseases Stories
COVA322 is First of Covagen's Bispecific FynomAbs to Enter Clinical Trials ZURICH-SCHLIEREN, Switzerland, May 5, 2014 /PRNewswire/ --
NEW YORK, May 3, 2014 /PRNewswire-USNewswire/ -- The South Street Seaport transformed into an ocean of purple as nearly 5,000 walkers came together in New York City to shed
May Lupus Research Awareness Month Campaign Aims to Enlist 1 Million To Work For a World Without Lupus NEW YORK, May 1, 2014 /PRNewswire/ -- To recognize World Lupus Day, May 10, the
- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated
Sephure® ensures proper placement of suppositories, improves patient quality of life and compliance CONCORD, Mass., May 1, 2014 /PRNewswire/ -- Jennifer Davagian Ensign, Founder &
Three new mango-related studies were presented this week at the 2014 Federation of American Societies for Experimental Biology (FASEB) in San Diego, revealing initial findings on the effects of mango consumption on ulcerative colitis and bone parameters in animal models.
- Initiation of Phase 1/2a clinical trial in subjects with dry eye disease expected mid-2014 DURHAM, N.C., May 1, 2014 /PRNewswire/ -- Parion Sciences, a company dedicated to the
May is Lupus Awareness Month; Lupus Foundation of America Education Programs and Events Taking Place Nationwide WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- In recognition of Lupus Awareness
Afternoon to Honor Robbyn Sockolow, MD; Hosted by Veteran TV News Anchor Liz Cho and featuring a Fashion Presentation by Bergdorf Goodman NEW YORK, April 30, 2014 /PRNewswire/ -- The
Expert Opinion Indicates That Humira and Cimzia Have the Best Clinical Profiles of Key Marketed Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., April 30, 2014
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.